Join MySLAS Social

Publications

2017 SLAS Discovery Editorial Board

Editor-in-Chief

Robert M. Campbell, Ph.D.
Editor-in-Chief
Eli Lilly & Company
Indianapolis, IN
USA

 

Associate Editors


Marc Bickle
Max Planck Institute of Molecular Cell Biology and Genetics
Dresden
Germany
 

Ricardo Macarron
GlaxoSmithKline
Collegeville, PA
USA
 

Christian Parker
Novartis Institutes for BioMedical Research
Basel
Switzerland
 
 

Reviews Editor


Peter Simpson
Medicines Discovery Catapult
Cheshire
United Kingdom
 

Editorial Board Members


James Beasley
Venenum Biodesign
Hamilton, NJ
USA
 

Christine Brideau
WuXi AppTec
Holmdel, NJ
USA
 

Hakim Djaballah
Keren Therapeutics
New York, NY
USA
 

Juan Manuel Dominguez
PharmaMar
Madrid
Spain
 

Frank Fan
Promega
Madison, WI
USA
 

Marc Ferrer
NIH Chemical Genomics Center
Rockville, MD
USA
 

Charles Hart
Threshold Pharmaceuticals
South San Francisco, CA
USA
 

Rob Howes
AstraZeneca
Gothenburg
Sweden
 

Manfred Jung
Albert-Ludwigs-Universität Freiburg
Freiburg
Germany
 

David J. Kahler
NYU High-Throughput Biology Laboratory
New York, NY
USA
 

Jose Julio Martin-Plaza
GlaxoSmithKline
Tres Cantos
Spain
 

Larry Mattheakis
Protagonist Therapeutics
Milpitas, CA
USA
 

James McGee
Eli Lilly & Company
Indianapolis, IN
USA
 

Joseph McGivern
Amgen Inc.
Thousand Oaks, CA
USA
 

Robert Nadon, Ph.D.
McGill University
Montreal, QC
Canada
 

Andrew Pope
GlaxoSmithKline
Collegeville, PA
USA
   

Katja Remlinger
GlaxoSmithKline
Raleigh-Durham, NC
USA
   

Timothy Spicer
The Scripps Research Institute
Jupiter, FL
USA
 

Masoud Vedadi
University of Toronto
Toronto, ON
Canada
 

Francisca Vicente
Fundación MEDINA
Granada
SPAIN

Mark Wade
Astex Pharmaceuticals
Cambridge
UK
 

Ming-Wei Wang
Chinese Academy of Sciences
Shanghai
China